CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

This is an archived document. The links are no longer being updated.

2004 Surveillance Slides

Primary Anti-TB Drug Resistance

United States, 1993–2004


Slide 19: Primary Anti-TB Drug Resistance, United States, 1993-2004
Slide 19. Primary Anti-TB Drug Resistance, United States, 1993–2004.  Primary drug resistance is shown for the previous 12 years.  The graph starts in 1993, the year in which the individual TB case reports submitted to the national surveillance system began collecting information on initial susceptibility test results for patients with culture-positive TB.  Data were available for more than 85% of culture-positive cases for each year.  Primary resistance was calculated by using data from persons with no reported prior TB episode.  Resistance to at least isoniazid remained between 7.0% and 8.4%.  However, resistance to at least isoniazid and rifampin, known as multidrug-resistant TB (MDR TB), decreased from 2.5% in 1993 to approximately 1.0% each year during 1997-2004.

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333